Top

Reactions Weekly

Published in:

01-07-2023 | Tocilizumab | Case report

Aspirin/clopidogrel/tocilizumab

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Suzuki K, et al. A severe cerebral infarction associated with giant cell arteritis, which developed during tocilizumab therapy and was successfully treated with intravenous cyclophosphamide. Modern Rheumatology Case Reports 7 : 453-457, No. 2, Jan 2023. Available from: URL: http://doi.org/10.1093/mrcr/rxad009

Title: Aspirin/clopidogrel/tocilizumab
Lack of efficacy: case report
Publication date: 01-07-2023
Publisher: Springer International Publishing
Keywords: Tocilizumab
Clopidogrel
Giant Cell Arteritis
Giant Cell Arteritis
Polymyalgia Arteritica
Polymyalgia Arteritica
Prednisolone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-43065-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Aspirin/clopidogrel/tocilizumab

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Immune-globulin/pembrolizumab/prednisone

Diazoxide-related necrotising enterocolitis in neonates and infants

Antiplatelets/HMG-CoA-reductase-inhibitors

Bevacizumab/carboplatin/doxorubicin

Anastrozole/cobalamin/vitamin-d

Ciclosporin/tacrolimus